Literature DB >> 16260556

Management of interstitial pregnancy using selective uterine artery embolization.

Philippe Deruelle1, Jean-Philippe Lucot, Christophe Lions, Yann Robert.   

Abstract

BACKGROUND: Interstitial pregnancy is a rare and dangerous form of ectopic pregnancy which is treated by surgery, medical treatment, or both. Management options are not standardized. Currently, conservative nonsurgical treatment seems to be an alternative method in case of interstitial pregnancy. CASE: A right interstitial pregnancy was diagnosed in a 28-year-old woman. She was successfully treated by 2 courses of systemic methotrexate (1 mg/kg) 24 hours apart followed by selective uterine artery embolization. The postembolization course was uneventful, and no rupture occurred. Ten weeks after embolization, human chorionic gonadotropin level was negative.
CONCLUSION: Uterine embolization associated with methotrexate can be used successfully in treating selected cases of early interstitial pregnancy. We hypothesize that this procedure combined with methotrexate could reduce hemorrhagic risk.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16260556     DOI: 10.1097/01.AOG.0000164070.13978.87

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  3 in total

Review 1.  Incidence, diagnosis and management of tubal and nontubal ectopic pregnancies: a review.

Authors:  Danielle M Panelli; Catherine H Phillips; Paula C Brady
Journal:  Fertil Res Pract       Date:  2015-10-15

2.  Selective uterine artery embolization for management of interstitial ectopic pregnancy.

Authors:  Seung Boo Yang; Sang Jin Lee; Hwan Sung Joe; Dong Erk Goo; Yun Woo Chang; Dong Hun Kim
Journal:  Korean J Radiol       Date:  2007 Mar-Apr       Impact factor: 3.500

3.  Interstitial ectopic pregnancy: conservative surgical management.

Authors:  Hussein Warda; Mamta M Mamik; Mohammad Ashraf; Mostafa I Abuzeid
Journal:  JSLS       Date:  2014 Apr-Jun       Impact factor: 2.172

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.